
Larry Anderson
Director of the Myeloma, Waldenström's, and Amyloidosis Program · UTSW’s Harold C. Simmons Comprehensive Cancer Center
Credentials: · · · · ·
History
- Present
Waldenström's · UTSW’s Harold C. Simmons Comprehensive Cancer Center
PresentPhase I Clinical Trial Research Program · UT Southwestern Medical Center
PresentCellular Immunotherapy and Autologous Stem Cell Transplant Program · UT Southwestern Medical Center
- 2003–2006
University of Washington Medical Center and Fred Hutchinson Cancer Research Center
- 2000–2003
- 1993–2000
UT Health Science Center McGovern Medical School
Research
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
New England Journal of Medicine · 2021 · 2,130 citations
Blood · 2020 · 617 citations
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
New England Journal of Medicine · 2022 · 422 citations

38 papers

37 papers
- DH
30 papers

30 papers

29 papers

29 papers

27 papers
- LS
26 papers
Clinical trials
- 2024–2027
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Principal investigator · Recruiting · Phase 1, Phase 2
University of Texas Southwestern Medical Center

